ArticleBMC gastroenterology2026
A nationwide retrospective study of the July effect on nonvariceal upper GI bleeding outcomes in teaching hospitals in the United States.
Article in BMC gastroenterology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
background"July effect" also known as "July phenomenon" are adverse patient outcomes related to the changeover of medical residents in teaching hospitals in the United States at a particular time of the year. This study aims to explore this phenomenon on hospital outcomes among patients with nonvariceal upper gastrointestinal bleeding (UGIB).
methodsThe National Inpatient Sample data from Jan 1, 2016, to Dec. 31, 2020, was used. Patients admitted in teaching hospitals between May and August were stratified patients into two groups; May & June; as (Non-July Effect), July & August as (July Effect). The study involved a comprehensive assessment and comparison of various clinical outcomes, including the likelihood of mortality, length of hospital stay, and the utilization and timing of esophagogastroduodenoscopy (EGD). These analyses were conducted while controlling factors such as socio-demographic variables, hospital characteristics, and associated comorbidities to ensure accurate and meaningful results.
resultsA total of 53,710 patients had non-variceal UGIB. There is no significant difference in Mortality risk (aOR = 1.10, 95% CI: 0.86-1.40, p = 0.4406), Length of hospitalization (0.98, 0.91-1.05, p = 0.5410), EGD (1.04, 0.94-1.32, p = 0.4412), and Early EGD (0.97, 0.80-1.19, p = 0.7759) between the July effect and non-July effect groups.
conclusionsThe analysis reveals no significant differences in mortality rates, length of hospitalization, or endoscopy and its timing among patients with UGIB during the July effect compared to those not affected by this phenomenon. Our study corroborates previous research on the July phenomenon while also exploring this phenomenon in upper gastrointestinal bleeding.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.